Advancements in Gastroenterology: A Weekly Review
Gastroenterologia
Gut Microbiome Therapies and Liver Disease Advances
Exploring groundbreaking research on gut microbiome therapies, liver disease advances, and novel approaches to gastroenterological conditions.
Accedi o Registrati per ascoltare questo episodio
Bibliografia
1. Fecal microbiota transplant overcomes resistance to anti-PD-1 therapy in melanoma patients.
Authors: Davar D, Dzutsev AK, McCulloch JA, et al.
Journal: Science (New York, N.Y.), 2021 Feb 5
PMID: 33542131
DOI: 10.1126/science.abf3363
2. Emerging therapeutic regimens as alternatives to glucocorticoids for severe alcohol-associated hepatitis: a comprehensive review.
Authors: Kumar R, Elangovan S, Asrani SK
Journal: Clinical and molecular hepatology, 2026 Apr
PMID: 41715264
DOI: 10.3350/cmh.2025.1163
3. Epigenetic scars of CD8(+) T cell exhaustion persist after cure of chronic infection in humans.
Authors: Yates KB, Tonnerre P, Martin GE, et al.
Journal: Nature immunology, 2021 Aug
PMID: 34312547
DOI: 10.1038/s41590-021-00979-1
4. Burden of malnutrition and sarcopenia in patients with cirrhosis: pathophysiology, assessment, and management.
Authors: Miwa T, Shimizu M, Schnabl B
Journal: Clinical and molecular hepatology, 2026 Apr
PMID: 41398617
DOI: 10.3350/cmh.2025.1126
5. Colorectal cancer screening.
Authors: Leggett BA, Hewett DG
Journal: Internal medicine journal, 2015 Jan
PMID: 25582937
DOI: 10.1111/imj.12636
6. A Phase 2 Randomized Trial of Survodutide in MASH and Fibrosis.
Authors: Sanyal AJ, Bedossa P, Fraessdorf M, et al.
Journal: The New England journal of medicine, 2024 Jul 25
PMID: 38847460
DOI: 10.1056/NEJMoa2401755
7. Randomized, Controlled Trial of the FGF21 Analogue Pegozafermin in NASH.
Authors: Loomba R, Sanyal AJ, Kowdley KV, et al.
Journal: The New England journal of medicine, 2023 Sep 14
PMID: 37356033
DOI: 10.1056/NEJMoa2304286
8. Colorectal cancer screening.
Authors: Leggett BA, Hewett DG
Journal: Internal medicine journal, 2015 Jan
PMID: 25582937
DOI: 10.1111/imj.12636
9. Randomized, Controlled Trial of the FGF21 Analogue Pegozafermin in NASH.
Authors: Loomba R, Sanyal AJ, Kowdley KV, et al.
Journal: The New England journal of medicine, 2023 Sep 14
PMID: 37356033
DOI: 10.1056/NEJMoa2304286
10. Calprotectin in inflammatory bowel disease.
Authors: Khaki-Khatibi F, Qujeq D, Kashifard M, et al.
Journal: Clinica chimica acta; international journal of clinical chemistry, 2020 Nov
PMID: 32818491
DOI: 10.1016/j.cca.2020.08.025
Authors: Davar D, Dzutsev AK, McCulloch JA, et al.
Journal: Science (New York, N.Y.), 2021 Feb 5
PMID: 33542131
DOI: 10.1126/science.abf3363
2. Emerging therapeutic regimens as alternatives to glucocorticoids for severe alcohol-associated hepatitis: a comprehensive review.
Authors: Kumar R, Elangovan S, Asrani SK
Journal: Clinical and molecular hepatology, 2026 Apr
PMID: 41715264
DOI: 10.3350/cmh.2025.1163
3. Epigenetic scars of CD8(+) T cell exhaustion persist after cure of chronic infection in humans.
Authors: Yates KB, Tonnerre P, Martin GE, et al.
Journal: Nature immunology, 2021 Aug
PMID: 34312547
DOI: 10.1038/s41590-021-00979-1
4. Burden of malnutrition and sarcopenia in patients with cirrhosis: pathophysiology, assessment, and management.
Authors: Miwa T, Shimizu M, Schnabl B
Journal: Clinical and molecular hepatology, 2026 Apr
PMID: 41398617
DOI: 10.3350/cmh.2025.1126
5. Colorectal cancer screening.
Authors: Leggett BA, Hewett DG
Journal: Internal medicine journal, 2015 Jan
PMID: 25582937
DOI: 10.1111/imj.12636
6. A Phase 2 Randomized Trial of Survodutide in MASH and Fibrosis.
Authors: Sanyal AJ, Bedossa P, Fraessdorf M, et al.
Journal: The New England journal of medicine, 2024 Jul 25
PMID: 38847460
DOI: 10.1056/NEJMoa2401755
7. Randomized, Controlled Trial of the FGF21 Analogue Pegozafermin in NASH.
Authors: Loomba R, Sanyal AJ, Kowdley KV, et al.
Journal: The New England journal of medicine, 2023 Sep 14
PMID: 37356033
DOI: 10.1056/NEJMoa2304286
8. Colorectal cancer screening.
Authors: Leggett BA, Hewett DG
Journal: Internal medicine journal, 2015 Jan
PMID: 25582937
DOI: 10.1111/imj.12636
9. Randomized, Controlled Trial of the FGF21 Analogue Pegozafermin in NASH.
Authors: Loomba R, Sanyal AJ, Kowdley KV, et al.
Journal: The New England journal of medicine, 2023 Sep 14
PMID: 37356033
DOI: 10.1056/NEJMoa2304286
10. Calprotectin in inflammatory bowel disease.
Authors: Khaki-Khatibi F, Qujeq D, Kashifard M, et al.
Journal: Clinica chimica acta; international journal of clinical chemistry, 2020 Nov
PMID: 32818491
DOI: 10.1016/j.cca.2020.08.025
